Southwest to Pour $...
Health Care: Drugs
Pfizer Inc (PFE: NYSE)
$22.14 0.05 | 0.23%
05/24/12 - 04:00 PM ET
26.09M / 38.56M
Vol / Avg. Vol:22.15 / 22.09
Open / Prev. Close:21.92 - 22.17
Today's Range:16.63 - 23.30
52 Wk Range:2.31%
Performance YTD:TheStreet Rating:
Portfolios with PFE
- Portfolio NameUser Type
- Contributor22 Biopharma Stocks With Br...
- Userdennis all star
- UserOne
- ProLee Ainslie - Maverick Capital
- Userbasket
- UserJFleckensteins favorite picks
- UserJARBAS ROCHA
- Userdividends
- ContributorDogs of the Dow
- Contributor10 Dividend Stocks Held by ...
Latest PFE Headlines from TheStreet
- Pfizer Inc (PFE): Today's Featured Drugs Loser 05.22.12 | 05:05 pm
- 22 Biopharma Stocks With Breakout Potential in 2012 05.22.12 | 08:05 am
- Monday's Top 10 Articles, Videos on TheStreet 05.21.12 | 01:05 pm
- Outlooks for Pfizer, Arena and Onyx Following Busy May 05.21.12 | 07:05 am
- 3 Stocks I Saw on TV, May 18
05.18.12 | 08:05 am - 3 Stocks I Saw on TV, May 17 05.17.12 | 07:05 am
- Pfizer, Glaxo, J&J Grab ASCO Spotlight 05.16.12 | 06:05 pm
- Pfizer Inc (PFE): Today's Featured Drugs Loser 05.15.12 | 05:05 pm
- A Health Care Fortnight for the Record Books 05.14.12 | 07:05 am
- Is Europe A Safe Place To Buy? Not Exactly 05.13.12 | 01:05 pm
Press Releases for PFE
- FDA Advisory Committee Finds Data Support Effectiveness Of Tafamidis Meglumine, Pfizer’s Novel Investigational Treatment For Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) - Business Wire 05.24.12 | 06:05 pm
- Pfizer Names Olivier Brandicourt As President And General Manager, Emerging Markets And Established Products Business Units - Business Wire 05.23.12 | 07:05 am
- Pfizer Teams With EatingWell To Launch Free Mobile App - PR Newswire 05.22.12 | 10:05 am
- Pfizer Invites Public To View And Listen To Webcast Of June 3 Pfizer Analyst And Investor Meeting At ASCO - Business Wire 05.22.12 | 10:05 am
- Pfizer Exploratory Study Measures Effects Of Lyrica (pregabalin) On Brain Activity In Fibromyalgia Patients - Business Wire 05.18.12 | 08:05 am
- Pfizer To Present New Data In Advanced Kidney, Lung And Hematologic Cancers At 2012 ASCO Annual Meeting - Business Wire 05.14.12 | 08:05 am
- Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference - Business Wire 05.10.12 | 10:05 am
- FDA Arthritis Advisory Committee Recommends Approval Of Tofacitinib For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis - Business Wire 05.09.12 | 03:05 pm
- Pfizer Announces New Long-Term Relapse Prevention Data For PRISTIQ® (desvenlafaxine) 50 Mg/day For The Treatment Of Major Depressive Disorder In Adults - Business Wire 05.07.12 | 08:05 am
- Pfizer Stops Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Neuropathic Pain Associated With HIV Neuropathy - Business Wire 05.04.12 | 08:05 am
Partner Headlines for PFE
- Analyst Alerts: Occidental, Pandora, Xueda Education, J&J, SAIC May 24th - Wall St. Cheat Sheet 05.24.12 | 10:05 am
- Dow Movers: Procter & Gamble Getting Green, McDonald's Japan Problem - Wall St. Cheat Sheet 05.23.12 | 03:05 am
- Health Care SPDR In Focus Ahead Of Obamacare Decision - Benzinga 05.22.12 | 12:05 pm
- The Definitive Biotech ETF Guide (IBB, XBI, FBT) - Benzinga 05.21.12 | 01:05 pm
- Generics Drive Dr. Reddy's - Analyst Blog - Zacks 05.14.12 | 09:05 am
- 4 New Reasons To Be Bullish On Sanofi Now - Seeking Alpha 05.13.12 | 09:05 am
- Stock Market News for May 11, 2012 - Market News - Zacks 05.11.12 | 10:05 am
- Earnings Scorecard: Bristol-Myers - Analyst Blog - Zacks 05.04.12 | 06:05 pm
- This Developmental Pharma Has Potential To Be A Long Term Multibagger - Seeking Alpha 05.03.12 | 09:05 am
- Company News for May 02, 2012 - Corporate Summary - Zacks 05.02.12 | 10:05 am
